We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$46.1B
AUM Growth
+$6.94B
Cap. Flow
+$2.24B
Cap. Flow %
4.85%
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$209M
2
AVGO icon
Broadcom
AVGO
+$207M
3
TJX icon
TJX Companies
TJX
+$195M
4
EMR icon
Emerson Electric
EMR
+$193M
5
FISV
Fiserv Inc
FISV
+$171M

Sector Composition

Rank Sector Weight
1 Technology 27.07%
2 Healthcare 17.55%
3 Financials 10.75%
4 Consumer Discretionary 9.77%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTR icon
526
Palantir
PLTR
$295B
$11.3M 0.02%
659,660
+336,360
+104% +$5.99M
THC icon
527
Tenet Healthcare
THC
$20.1B
$11.3M 0.02%
+149,070
New +$9.45M
OKTA icon
528
Okta
OKTA
$24.1B
$11.2M 0.02%
123,692
+32,085
+35% +$2.45M
TTWO icon
529
Take-Two Interactive
TTWO
$43B
$11M 0.02%
68,601
+28,498
+71% +$4.25M
NBIX icon
530
Neurocrine Biosciences
NBIX
$17.7B
$11M 0.02%
83,633
+80,420
+2,503% +$9.26M
TTD icon
531
Trade Desk
TTD
$8.13B
$11M 0.02%
152,854
+76,655
+101% +$5.63M
BNTX icon
532
BioNTech
BNTX
$22.6B
$11M 0.02%
+103,858
New +$10.5M
WEC icon
533
WEC Energy
WEC
$37.7B
$10.9M 0.02%
129,890
+54,623
+73% +$4.5M
CYTK icon
534
Cytokinetics
CYTK
$11B
$10.9M 0.02%
+130,260
New +$4.72M
GRMN
535
Garmin
GRMN
$46.9B
$10.9M 0.02%
84,425
+31,413
+59% +$3.64M
CAH icon
536
Cardinal Health
CAH
$53.4B
$10.7M 0.02%
105,924
-50,477
-32% -$5.01M
AER icon
537
AerCap
AER
$23.9B
$10.6M 0.02%
143,100
+45,118
+46% +$2.98M
AVY icon
538
Avery Dennison
AVY
$12.3B
$10.6M 0.02%
52,345
+13,959
+36% +$2.61M
WTW icon
539
Willis Towers Watson
WTW
$27.9B
$10.6M 0.02%
43,754
+17,565
+67% +$4.06M
DASH icon
540
DoorDash
DASH
$75.3B
$10.5M 0.02%
106,045
+54,674
+106% +$4.84M
ALGN icon
541
Align Technology
ALGN
$12B
$10.4M 0.02%
38,134
+7,665
+25% +$1.82M
SUI icon
542
Sun Communities
SUI
$15B
$10.2M 0.02%
76,538
+19,314
+34% +$2.33M
NTAP icon
543
NetApp
NTAP
$32.9B
$10.2M 0.02%
115,880
+62,295
+116% +$5.01M
KRTX
544
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$10.2M 0.02%
+32,217
New +$6.26M
VIPS icon
545
Vipshop
VIPS
$6.84B
$10.2M 0.02%
571,848
+14,547
+3% +$227K
SWKS icon
546
Skyworks Solutions
SWKS
$9.06B
$10.1M 0.02%
90,031
+30,022
+50% +$2.94M
APLS
547
DELISTED
Apellis Pharmaceuticals
APLS
$10.1M 0.02%
+169,051
New +$8.58M
RY icon
548
Royal Bank of Canada
RY
$291B
$10.1M 0.02%
100,000
+10,000
+11% +$881K
MTB icon
549
M&T Bank
MTB
$36.2B
$9.99M 0.02%
72,860
+31,930
+78% +$4.01M
DOV icon
550
Dover
DOV
$27.2B
$9.91M 0.02%
64,405
+25,464
+65% +$3.57M

Similar funds

Aberdeen Group's Q4 2023 Portfolio in Review

As of Q4 2023, Aberdeen Group held 995 positions worth $46.1B, up 18% from $39.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aberdeen Group deployed $2.24B of net new capital in Q4 2023, opening 107 new positions and adding to 596 existing holdings. Its largest new stake was Veralto: 984,184 shares worth $81M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $209M trimmed.

  • Aberdeen Group's largest Q4 2023 buy was Veralto: 984,184 shares worth $81M.
  • Aberdeen Group added most to NVIDIA in Q4 2023, an estimated $231M increase.
  • Aberdeen Group's biggest Q4 2023 reduction was Microsoft, cutting an estimated $209M.
  • Aberdeen Group fully exited VMware, Inc in Q4 2023, selling an estimated $61M.
  • Aberdeen Group's ten largest holdings make up 24% of its $46.1B portfolio in Q4 2023.
  • Aberdeen Group opened 107 new positions and closed 35 in Q4 2023.
  • Aberdeen Group's portfolio value rose 18% quarter-over-quarter to $46.1B.

Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.